Ana Clara Assis Alves Emerick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Clara Assis Alves Emerick has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Braga
Department of Gynecology and Obstetrics, School of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 22240-003, RJ, Brazil
1 shared publication - Edward Araujo Júnior
Department of Obstetrics Paulista School of Medicine, Federal University of São Paulo (EPM‐UNIFESP) São Paulo Brazil
1 shared publication - Evelyn Traina
Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil
1 shared publication - Gloria Calagna
Villa Sofia Cervello Hospital, University of Palermo, 90100 Palermo, Italy
1 shared publication - Gustavo Yano Callado
Albert Einstein Israelite College of Health Sciences (FICSAE), Albert Einstein Israelite Hospital, São Paulo 05652-900, SP, Brazil
1 shared publication - Letícia Castilho Yamanaka
Discipline of Woman Health, Municipal University of São Caetano do Sul (USCS), São Caetano do Sul 09521-160, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 28 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1886
HTLV-1 in Pregnancy and Neonatal Health: Evidence, Challenges, and Future Directions
Human T-cell lymphotropic virus (HTLV), a retrovirus associated with severe conditions such as leukemia/lymphoma and myelopathy, exhibits variable global prevalence, with higher rates observed in regions such as northeastern Brazil and sub-Saharan Africa. While intrauterine transmission can occur via viral expression in placental tissue and contact with umbilical cord blood, the predominant route is vertical transmission through breastfeeding. Diagnostic testing, particularly serological screening with ELISA and confirmatory methods such as Western blot and PCR, is essential for early detection during pregnancy. The implementation of prenatal screening programs, as seen in Japan and Brazil, has proven effective in reducing vertical transmission by guiding interventions such as breastfeeding cessation in infected mothers. Beyond clinical implications, the psychosocial impact on affected pregnant women highlights the need for an interdisciplinary approach. Although the association between HTLV infection and adverse obstetric outcomes remains controversial, studies suggest increased risks of preterm birth, low birth weight, and other neonatal complications. Given the importance of early diagnosis and prevention, universal prenatal screening protocols represent a critical strategy to reduce viral transmission and its long-term consequences.
- 28 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1886
Open AccessHTLV-1 in Pregnancy and Neonatal Health: Evidence, Challenges, and Future Directions
Human T-cell lymphotropic virus (HTLV), a retrovirus associated with severe conditions such as leukemia/lymphoma and myelopathy, exhibits variable global prevalence, with higher rates observed in regions such as northeastern Brazil and sub-Saharan Africa. While intrauterine transmission can occur via viral expression in placental tissue and contact with umbilical cord blood, the predominant route is vertical transmission through breastfeeding. Diagnostic testing, particularly serological screening with ELISA and confirmatory methods such as Western blot and PCR, is essential for early detection during pregnancy. The implementation of prenatal screening programs, as seen in Japan and Brazil, has proven effective in reducing vertical transmission by guiding interventions such as breastfeeding cessation in infected mothers. Beyond clinical implications, the psychosocial impact on affected pregnant women highlights the need for an interdisciplinary approach. Although the association between HTLV infection and adverse obstetric outcomes remains controversial, studies suggest increased risks of preterm birth, low birth weight, and other neonatal complications. Given the importance of early diagnosis and prevention, universal prenatal screening protocols represent a critical strategy to reduce viral transmission and its long-term consequences.